Inventor · disambiguated record
Yasamin Moazami
Also filed as: MOAZAMI YASAMIN
12 granted patents·12 pending applications·22 citations·filing 2019–2025
86Inventor score
Files withGILEAD SCIENCES INC24
Top patents by PatentIndex Score
24 records- 0194US11224600B2Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Jan 18, 2022·9 cites·21 claims
- 0289US11845723B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Dec 19, 2023·3 cites·41 claims
- 0389US11179383B2Compounds for inhibition of α4β7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·3 cites·20 claims
- 0488US11976072B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 7, 2024·1 cites·19 claims
- 0583US11174256B2Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 16, 2021·2 cites·18 claims
- 0683US11116760B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2019·Granted Sep 14, 2021·3 cites·23 claims
- 0780US2025361236A9Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 0879US11578069B2Compounds for inhibition of α4 β7 integrinGILEAD SCIENCES INC·Filed 2020·Granted Feb 14, 2023·1 cites·11 claims
- 0977US2025032473A1Quinoline derivativesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1075US2025049780A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1173US12070455B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted Aug 27, 2024·0 cites·29 claims
- 1273US2025163030A1Pyridizin-3(2h)-one derivativesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1369US11661431B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 30, 2023·0 cites·53 claims
- 1469US2023365594A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1568US12053462B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2021·Granted Aug 6, 2024·0 cites·18 claims
- 1667US12459922B2PARP7 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Nov 4, 2025·0 cites·16 claims
- 1766US2023183216A1Pyridizin-3(2h)-one derivativesGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 1865US2022226337A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 1965US2022152014A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2063US2022135561A1Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2162US2025100998A1Parp7 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2262US2025066328A1Parp7 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2359US11926628B2Diacylglyercol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 2448US2025353817A1Interlukin-17a inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasamin Moazami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →